logo

For the Inventor, By the Inventor

Washington, DC, United States of America

Stephen M Feinstone

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent, primarily in HCV Vaccines. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Secretary of. Active years: 1985-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen M Feinstone. Retrieved from https://idiyas.com/inventor/stephen-m-feinstone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 77.8


Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 274(Granted Patents)


Location History:

  • Boyds, MD (US) (1986)
  • Washington, DC (US) (1985 - 2016)

Company Filing History:

goldMedal7 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
silverMedal7 out of 3,713 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
bronzeMedal2 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
4. 1 out of 28 
 
The United States of America as Represented by the Secretary of Health
 patents
5. 1 out of 834,708 
Other
 patents

Years Active: 1985-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Hepatitis C
Neutralizing Antibody
Peptide Immunogens
HCV Vaccine
Hepatitis A
Chimeric Vaccine
DNA Techniques
Viral Inactivation
Peptide Vaccines
Cloned DNA
Nucleic Acid Amplification
Virus Detection
18 patents (USPTO):Explore Patents
1. 9399672 - Hepatitis C virus neutralizing antibody (2016-07-26),
2. 8603468 - Neutralization of HCV (2013-12-10),
3. 7341726 - Modified HCV peptide immunogens (2008-03-11),
4. 7074410 - Modified HCV peptide vaccines (2006-07-11),
5. 6685944 - Modified HCV peptide vaccines (2004-02-03),
6. RE37381 - Vaccine against hepatitis A virus (2001-09-18),
7. 5980899 - Identification of peptides that stimulate hepatitis C virus specific (1999-11-09),
8. 5837260 - Chimeric hepatitis A vaccine (1998-11-17),
9. 5622861 - Recombinant DNA encoding hepatitis A virus receptor (1997-04-22),
10. 5516630 - Methods of detecting hepatitis A virus (1996-05-14),
11. 5284760 - Techniques for producing site-directed mutagenesis of cloned DNA (1994-02-08),
12. 5104792 - Method for amplifying unknown nucleic acid sequences (1992-04-14),
13. 4636469 - Isolation of hepatitis A virus strain HM-175 (1987-01-13),
14. 4620978 - Hepatitis A virus purified and triply cloned (1986-11-04),
15. 4615886 - Utilizing a halohydrocarbon containing dissolved water to inactivate a (1986-10-07),

Title: The Innovative Journey of Stephen M. Feinstone

Introduction: Stephen M. Feinstone is a pioneering inventor based in Washington, DC, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Stephen M. Feinstone holds several patents in various technological domains, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: Throughout his illustrious career, Stephen M. Feinstone has consistently demonstrated a keen eye for identifying gaps in the market and developing inventive solutions to address them. His innovative spirit has led to the creation of numerous cutting-edge technologies that have revolutionized the industry.

Collaborations: Stephen M. Feinstone has collaborated with leading experts in the field, fostering a culture of innovation and knowledge-sharing. His partnerships have resulted in the development of groundbreaking inventions that have left a lasting impact on the technological landscape.

Conclusion: Stephen M. Feinstone's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his reputation as a visionary inventor in Washington, DC, and beyond. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…